The Current Health Status of Patients Living With Type 1 Diabetes From the LMC Diabetes Patient Registry
Type 1 Diabetes in Canada: The Demographic, Care Profiles and Glycemic Control of Patients Living With Type 1 Diabetes From the LMC Diabetes Patient Registry
1 other identifier
observational
3,600
1 country
1
Brief Summary
This retrospective study uses the Canadian LMC Diabetes Registry to describe the current health status of Canadians with type 1 diabetes. The study provides a detailed report of the demographic composition, treatment regimens, self-care approaches, health status, metabolic outcomes, and glycemic control of a large Canadian community-based, specialist-led cohort of patients with type 1 diabetes. Specific study outcomes will also be evaluated in a subgroup of patients using continuous subcutaneous insulin infusion (CSII) therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2019
CompletedFirst Posted
Study publicly available on registry
November 14, 2019
CompletedStudy Start
First participant enrolled
January 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2020
CompletedJanuary 28, 2020
January 1, 2020
14 days
November 10, 2019
January 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
HbA1c
HbA1c will be measured by accessing patients medical records and it will be evaluated at one time point only. The value will be the last measured value for each patient between January 2015 and June 2019
1 day
Secondary Outcomes (29)
Fasting plasma glucose
1 day
Proportion of patients with HbA1c ≤7.0%, 7.1 to 8.0%, 8.1 to 9.0% and >9.0%
1 day
Lipid parameters
1 day
Proportion of patients below and above target LDL cholesterol
1 day
Blood pressure
1 day
- +24 more secondary outcomes
Other Outcomes (26)
Mean CGM glucose
5 to 90 days
Time in range
5 to 90 days
Time in hypoglycemia
5 to 90 days
- +23 more other outcomes
Eligibility Criteria
Patients with type 1 diabetes under the care of an endocrinologist at an LMC Healthcare centre, in the provinces of Ontario, Quebec, or Alberta, Canada.
You may qualify if:
- Clinical diagnosis of type 1 diabetes for ≥ 6 months
- Assessed by an LMC endocrinologist between July 1, 2015 and June 30, 2018
- Followed by an LMC endocrinologist for \> 6 months
- Informed consent provided and signed for medical record data to be used for research purposes
You may not qualify if:
- clinical diagnosis of type 2 diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
LMC Healthcare
Toronto, Canada
Related Publications (1)
Aronson R, Brown RE, Abitbol A, Goldenberg R, Yared Z, Ajala B, Yale JF. The Canadian LMC Diabetes Registry: A Profile of the Demographics, Management, and Outcomes of Individuals with Type 1 Diabetes. Diabetes Technol Ther. 2021 Jan;23(1):31-40. doi: 10.1089/dia.2020.0204. Epub 2020 Jul 31.
PMID: 32667835DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ronnie Aronson, MD
LMC Healthcare
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 10, 2019
First Posted
November 14, 2019
Study Start
January 6, 2020
Primary Completion
January 20, 2020
Study Completion
January 20, 2020
Last Updated
January 28, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share